WAVE Life Sciences (WVE)
(Delayed Data from NSDQ)
$8.63 USD
+0.53 (6.54%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $8.62 -0.01 (-0.12%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
WAVE Life Sciences Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
WVE 8.63 +0.53(6.54%)
Will WVE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WVE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WVE
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
WVE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates
Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates
Myriad Genetics (MYGN) Reports Q1 Loss, Misses Revenue Estimates
Other News for WVE
WVE: Analyst Lowers Price Target While Maintaining Overweight Rating | WVE Stock News
WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ...
Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript
Decoding WAVE Life Sciences Ltd (WVE): A Strategic SWOT Insight
Wave Life Sciences (WVE) Advances RNA Editing Programs Amid Financial Challenges